EV/EBITDA:
15.48+0.19(+1.24%)Summary
- As of today, SUPN EV/EBITDA is 15.48, with a rise of +0.19 (+1.24%) during the most recent trading session on October 16, 2025.
- Over the past year, SUPN EV/EBITDA has increased by +5.79 (+59.75%).
- SUPN EV/EBITDA is now -69.55% below its all-time high of 50.83.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.2% | +1.2% | +1.0% |
| 1M1 Month | +16.4% | +16.4% | +13.1% |
| 3M3 Months | +65.4% | +65.4% | +48.5% |
| 6M6 Months | +86.3% | +78.5% | +62.0% |
| YTDYTD | +49.1% | +44.0% | +37.6% |
| 1Y1 Year | +59.8% | +52.1% | +46.4% |
| 5Y5 Years | +163.7% | +99.0% | +144.0% |
SUPN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 15.48 | at high | 13.30 | +16.4% |
| 3M | 3-Month | 15.48 | at high | 8.91 | +73.7% |
| 6M | 6-Month | 15.48 | at high | 8.16 | +89.7% |
| 1Y | 1-Year | 15.48 | at high | 8.16 | +89.7% |
| 3Y | 3-Year | 19.33 | -19.9% | 8.16 | +89.7% |
| 5Y | 5-Year | 19.33 | -19.9% | 5.15 | +200.6% |
| All-Time | All-Time | 50.83 | -69.5% | -13.01 | +219.0% |
SUPN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 15.48(+49.1%) |
| 2024 | 10.38(-25.6%) |
| 2023 | 13.95(-4.3%) |
| 2022 | 14.57(+18.8%) |
| 2021 | 12.26(+89.2%) |
| 2020 | 6.48(-63.9%) |
| Date | Value |
|---|---|
| 2017 | 17.94(-15.8%) |
| 2016 | 21.31(-29.5%) |
| 2015 | 30.21(+118.9%) |
| 2014 | 13.80(+378.8%) |
| 2013 | -4.95(-1.2%) |
| 2012 | -4.89 |
FAQ
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of SUPN is 15.48
What is the all-time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high EV/EBITDA is 50.83
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals, Inc. EV/EBITDA has changed by +5.10 (+49.13%) since the beginning of the year
What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by +5.79 (+59.75%)